Biphasic Insulin Aspart 30 Therapy in Insulin-Naïve and Insulin-Experienced Patients with Type 2 Diabetes: Results from the Jordanian Subgroup of the A1chieve Study
Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51841#.VHfSm2fHRK0 Author(s) Jihad Haddad 1* , Fares H. Haddad 2 , Rashad Nasser 3 , Abdel-Ellah Al-Shudifat 1 , Firas Abbas Annabi 4 , Levent Sandalci 5 , Moawia Al-Kilani 6 Affiliation(s) 1 Prince Hamzah Hospital, Amman, Jordan . 2 King Hussein Medical Center, Amman, Jordan . 3 Italian Hospital, Amman, Jordan . 4 Islamic Hospital, Amman, Jordan . 5 Novo Nordisk Business Area Near East, Istanbul, Turkey . 6 Jabal Al Zayton Hospital, Zarqa, Jordan . ABSTRACT Objective: To analyse the safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in a Jordanian subgroup of the 24-week, non-interventional A 1 chieve study. Metho...